当前位置:首页 - 行情中心 - 硕世生物(688399) - 财务分析 - 现金流量表

硕世生物

(688399)

  

流通市值:62.97亿  总市值:62.97亿
流通股本:8387.17万   总股本:8387.17万

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金292,105,131.01178,751,188.3494,839,811.21473,244,427.8
  收到的税费返还350,784.1249,891.45160,366.6833,967.56
  收到其他与经营活动有关的现金23,785,862.2215,841,458.4212,698,772.37105,724,030.19
  经营活动现金流入小计316,241,777.33194,842,538.21107,698,950.18579,802,425.55
  购买商品、接受劳务支付的现金69,672,483.5649,621,065.0629,238,486.9675,777,350.62
  支付给职工以及为职工支付的现金126,002,783.1882,334,999.0241,855,416.88210,815,749.17
  支付的各项税费14,362,146.039,189,545.394,523,553.2717,706,583.29
  支付其他与经营活动有关的现金86,779,411.5954,272,568.5427,814,237.84129,577,430.94
  经营活动现金流出小计296,816,824.36195,418,178.01103,431,694.95433,877,114.02
  经营活动产生的现金流量净额19,424,952.97-575,639.84,267,255.23145,925,311.53
二、投资活动产生的现金流量:
  收回投资收到的现金3,609,526,290.912,390,726,848.831,284,127,379.022,357,197,275.06
  取得投资收益收到的现金321,661.96323,629.021,284,793.99-
  处置固定资产、无形资产和其他长期资产收回的现金净额1,139,165.76860,115.3414,759.194,234,621.82
  收到的其他与投资活动有关的现金1,416,802.94--130,008,906.08
  投资活动现金流入小计3,612,403,921.572,391,910,593.151,285,826,932.22,491,440,802.96
  购建固定资产、无形资产和其他长期资产支付的现金55,390,132.4835,341,562.725,763,683.2862,861,301.79
  投资支付的现金4,012,153,960.042,834,371,918.591,900,416,693.923,301,592,708.85
  投资活动现金流出小计4,067,544,092.522,869,713,481.311,906,180,377.23,364,454,010.64
  投资活动产生的现金流量净额-455,140,170.95-477,802,888.16-620,353,445-873,013,207.68
三、筹资活动产生的现金流量:
  取得借款收到的现金551,500,000404,900,000267,900,000442,500,000
  收到其他与筹资活动有关的现金1,146,675.78---
  筹资活动现金流入小计552,646,675.78404,900,000267,900,000442,500,000
  偿还债务支付的现金332,900,000235,000,000130,000,000371,803,000
  分配股利、利润或偿付利息支付的现金290,918,633.073,554,078.711,392,361.227,077,171.15
  支付其他与筹资活动有关的现金7,401,602.382,596,916.021,254,419.92158,375,330.81
  筹资活动现金流出小计631,220,235.45241,150,994.73132,646,781.14537,255,501.96
  筹资活动产生的现金流量净额-78,573,559.67163,749,005.27135,253,218.86-94,755,501.96
四、汇率变动对现金及现金等价物的影响-1,448,843.2684,913.99116,855.06849,714.75
五、现金及现金等价物净增加额-515,737,620.91-314,544,608.7-480,716,115.85-820,993,683.36
  加:期初现金及现金等价物余额810,008,120.6810,008,120.6810,008,120.61,631,001,803.96
  期末现金及现金等价物余额294,270,499.69495,463,511.9329,292,004.75810,008,120.6
补充资料:
  净利润-3,992,614.61--2,001,695.81
  资产减值准备-8,875,990.18-25,015,532.3
  固定资产和投资性房地产折旧-24,061,207.33-48,520,362.26
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-24,061,207.33-48,520,362.26
  无形资产摊销-1,159,973.32-2,527,744.38
  长期待摊费用摊销-8,454,134.1-20,569,072.84
  处置固定资产、无形资产和其他长期资产的损失--329,458.59--2,223,291.77
  固定资产报废损失-13,877.86-153,324.03
  公允价值变动损失--24,119,828.2--2,182,658.64
  财务费用-5,140,158.69-6,647,854.54
  投资损失--3,678,436.1-1,350,660.89
  递延所得税-3,020,246.11-6,251,840.24
  其中:递延所得税资产减少-3,020,246.11-6,254,683.78
    递延所得税负债增加----2,843.54
  存货的减少-6,646,044.57-11,131,231.79
  经营性应收项目的减少-35,539,325.34-16,853,310.68
  经营性应付项目的增加--67,466,454.1-41,739,592.72
  其他-55,902.15-31,296.24
  现金的期末余额-495,463,511.9-810,008,120.6
  减:现金的期初余额-810,008,120.6-1,631,001,803.96
  现金及现金等价物的净增加额--314,544,608.7--820,993,683.36
公告日期2025-10-252025-08-092025-04-302025-04-19
审计意见(境内)标准无保留意见
TOP↑